NCT02378428View on ClinicalTrials.gov

MIBG Therapy for Patients With MIBG Avid Tumors

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

March 1, 2014

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
MIBG Avid Tumors
Interventions
DRUG

MIBG

Trial Locations (1)

43205

Nationwide Children's Hospital, Columbus

All Listed Sponsors
lead

Nationwide Children's Hospital

OTHER

NCT02378428 - MIBG Therapy for Patients With MIBG Avid Tumors | Biotech Hunter | Biotech Hunter